SecBot SecBot
8-K ·Filed Nov 5, 2026

TXG

10x Genomics, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed11d 7h ago SEC0001628280-26-071025
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The raised guidance and Atera commercial launch are the key catalysts. Monitor Atera adoption and consumables pull-through in Q4; the raised midpoint implies ~$630M for FY2026, above the prior $620M midpoint.

DirectionBullish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

10x Genomics reported Q3 2026 revenue of $150.7M (+1% YoY), slightly above the $147.8M consensus, and a GAAP net loss per share of $(0.15), which is narrower than the Street consensus estimate of $(0.29). The company raised its full-year 2026 revenue guidance to $625M-$635M (from $610M-$630M) and began commercial shipments of the Atera platform, a key catalyst.

Key Financial Metrics

EPS
−$0.15
est −$0.29 · +48.3%
Revenue
$150.7M
est $147.8M · +2.0% · +1.1% YoY
Rating
beat
Guidance
$625M-$635M
raised
Gross Margin
75%

Key Facts

  • Q3 2026 revenue $150.7M, +1% YoY vs $149.0M in Q3 2025
  • GAAP net loss per share $(0.15) vs $(0.22) in Q3 2025; Street consensus was $(0.29)
  • Gross margin improved to 75% from 67% a year ago
  • Full-year 2026 revenue guidance raised to $625M-$635M from $610M-$630M
  • Began global commercial shipments of Atera spatial biology platform
  • Introduced Sentira cloud analysis platform with NVIDIA and Anthropic AI
  • Cash and marketable securities $575.7M as of September 30, 2026

Financial Impact

Revenue $150.7M, net loss $(19.4M), operating loss $(16.1M), gross margin 75%

revenuegross marginnet lossguidance

Segment Breakdown

SegmentRevenueGrowth
Single Cell Consumables$93.1M+0.7%
Spatial Consumables$41.2M+16.4%
Single Cell Instruments$3.8M-23.2%
Spatial Instruments$3.1M-56.5%
Services$9.0M+11.0%

Risk Factors

  • Revenue growth remains modest at 1% YoY; reliance on Atera ramp for acceleration
  • Operating loss persists at $(16.1M); path to profitability not yet established
  • Litigation expenses could fluctuate; contingent consideration liabilities remain

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
48% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-071025
Document: txg-20261105.htm0001628280-26-071025
Document: 0001628280-26-071025-index-headers.html0001628280-26-071025
Document: 0001628280-26-071025-index.html0001628280-26-071025
Document: 0001628280-26-071025.txt0001628280-26-071025
8-K Data (Synthetic)0001628280-26-071025

Track record

28 reports on TXG

Performance horizon

1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
  2. Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
  3. Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
  4. Nov 5, 202611d ago 8-K Bullish 6/10 Viewing No price data
  5. Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
  6. Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
  7. Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
  8. Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
  9. Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
  10. Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
Showing 10 of 28

US Market Status

Market Closed · Opens Wed (9h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026